Joachim Köchling
About
In The Last Decade
Joachim Köchling
15 papers receiving 365 citations
Peers
Comparison fields: 5 of 50
- Surgery 135
- Immunology 100
- Hematology 91
- Public Health, Environmental and Occupational Health 82
- Molecular Biology 73
Countries citing papers authored by Joachim Köchling
This map shows the geographic impact of Joachim Köchling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Köchling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Köchling more than expected).
Fields of papers citing papers by Joachim Köchling
This network shows the impact of papers produced by Joachim Köchling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Köchling. The network helps show where Joachim Köchling may publish in the future.
Co-authorship network of co-authors of Joachim Köchling
This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Köchling. A scholar is included among the top collaborators of Joachim Köchling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Köchling. Joachim Köchling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 19 | |
| 4 | 14 | |
| 5 | 8 | |
| 6 | 53 | |
| 7 | Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides. | 19 |
| 8 | 3 | |
| 9 | 75 | |
| 10 | 36 | |
| 11 | 23 | |
| 12 | 21 | |
| 13 | 55 | |
| 14 | The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients. | 42 |
| 15 | 1 | |
| 16 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.